Current siRNA targets in atherosclerosis and aortic aneurysm

Area of Science:

• Cardiovascular Research
• Molecular Biology
• RNA Therapeutics

Background:

• Atherosclerosis (ATH) and aortic aneurysms (AA) are leading causes of morbidity and mortality.
• Current treatments for ATH and AA have limitations.
• RNA interference (RNAi) offers a potential therapeutic strategy.

Purpose of the Study:

• To review current gene targets for RNAi in ATH and AA.
• To discuss novel approaches in small interfering RNA (siRNA) delivery.
• To highlight challenges and future directions for RNAi-based therapies.

Main Methods:

• Literature review of studies published between 2010 and 2014.
• Focus on siRNA targets and delivery systems for ATH and AA.
• Analysis of preclinical and clinical feasibility studies.

Main Results:

• Multiple gene targets have been investigated for their role in ATH and AA.
• Various siRNA delivery strategies are being explored to improve efficacy and specificity.
• Key challenges include target validation, tissue specificity, and off-target effects.

Conclusions:

• RNAi holds significant potential for treating atherosclerosis and aortic aneurysms.
• Addressing challenges in siRNA delivery and target validation is crucial for clinical translation.
• Continued research is needed to optimize RNAi-based therapies for cardiovascular diseases.